نتائج البحث - "Philipp Le Coutre"

71

دورية أكاديمية

Asciminib, a Specific Allosteric BCR-ABL1 Inhibitor, in Patients with Chronic Myeloid Leukemia Carrying the T315I Mutation in a Phase 1 Trial

المؤلفون: Delphine Rea, Fabian Lang, Dong-Wook Kim, Jorge E. Cortes, Timothy P. Hughes, Hironobu Minami, Massimo Breccia, Daniel J. Deangelo, Andreas Hochhaus, Moshe Talpaz, Yeow Tee Goh, Philipp le Coutre, Michael W. Deininger, Gabriel Etienne, Manu Sondhi, Kaushal Mishra, Paola Aimone, Janet Ng-Sikorski, Michael J. Mauro

المساهمون: Rea, Delphine, Lang, Fabian, Kim, Dong-Wook, Cortes, Jorge E., Hughes, Timothy P., Minami, Hironobu, Breccia, Massimo, Deangelo, Daniel J., Hochhaus, Andrea, Talpaz, Moshe, Tee Goh, Yeow, le Coutre, Philipp, Deininger, Michael W., Etienne, Gabriel, Sondhi, Manu, Mishra, Kaushal, Aimone, Paola, Ng-Sikorski, Janet, Mauro, Michael J.

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000454837602170; volume:132; issue:1; journal:BLOOD; https://hdl.handle.net/11573/1685284Test

الإتاحة: https://doi.org/10.1182/blood-2018-99-113609Test
https://hdl.handle.net/11573/1685284Test

View record in BASE

72

Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study

المصدر: American Journal of Hematology. 90:910-914

مصطلحات موضوعية: medicine.medical_specialty, Hematology, business.industry, Myeloid leukemia, Imatinib, medicine.disease, Surgery, Discontinuation, Clinical trial, Leukemia, Imatinib mesylate, hemic and lymphatic diseases, Internal medicine, Predictive value of tests, medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::5280a83ba4cf3ff2859b8385d03e0d8cTest
https://doi.org/10.1002/ajh.24120Test

73

Nilotinib Vs Nilotinib Plus Pegylated Interferon α (Peg-IFN) Induction and Nilotinib or Peg-IFN Maintenance Therapy for Newly Diagnosed BCR-ABL1 Positive Chronic Myeloid Leukemia Patients in Chronic Phase (TIGER Study): The Addition of Peg-IFN Is Associated with Higher Rates of Deep Molecular Response

المصدر: Blood. 134:495-495

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3a1bde2ed8458f31623e383deba583d5Test
https://doi.org/10.1182/blood-2019-130043Test

74

Long-Term Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Receiving Frontline Nilotinib Versus Imatinib: Enestnd 10-Year Analysis

المصدر: Blood. 134:2924-2924

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Immunology, Vascular toxicity, Imatinib, Cell Biology, Hematology, Biochemistry, Treatment failure, Discontinuation, Clinical trial, Imatinib mesylate, Nilotinib, Internal medicine, medicine, business, Accelerated phase, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c333445495ab19add2475bb94507ef70Test
https://doi.org/10.1182/blood-2019-128761Test

75

Association of High Body Mass Index with Response Outcomes in Patients with CML-CP Treated with Dasatinib Versus Imatinib in the First Line: Exploratory Post Hoc Analysis of the Phase 3 DASISION Trial

المؤلفون: Sai Praneeth Reddy Bathena, Elias Jabbour, Giuseppe Saglio, Jorge E. Cortes, Alexander Brun, Philipp le Coutre, Neil P. Shah, Massimo Breccia, Irene DeGutis, Oumar Sy, Antonio Jiménez-Velasco

المصدر: Blood. 134:4155-4155

مصطلحات موضوعية: medicine.medical_specialty, business.industry, First line, Immunology, Imatinib, Cell Biology, Hematology, Guideline, Biochemistry, Dasatinib, Imatinib mesylate, hemic and lymphatic diseases, Internal medicine, Post-hoc analysis, Medicine, In patient, business, High body mass index, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::10af93690fce31be145bce32c3b12d20Test
https://doi.org/10.1182/blood-2019-121872Test

76

Cross-Intolerance with Bosutinib after Prior Tyrosine Kinase Inhibitors in Patients with Chronic Phase Chronic Myeloid Leukemia: BYOND Phase 4 Study

المؤلفون: Philipp le Coutre, Gianantonio Rosti, Justin M. Watts, Eric Leip, Jorge E. Cortes, Guillermo Ortí, Bjørn Tore Gjertsen, Frank Giles, Carlo Gambacorti-Passerini, Andrea Viqueira, Andreas Hochhaus

المصدر: Blood. 134:1639-1639

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Immunology, Drug intolerance, Imatinib, Cell Biology, Hematology, Biochemistry, Discontinuation, Dasatinib, Imatinib mesylate, Nilotinib, Internal medicine, Medicine, business, Adverse effect, Bosutinib, health care economics and organizations, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f7fbc0097e99af47221ae195bf9a1438Test
https://doi.org/10.1182/blood-2019-121815Test

77

Moxetumomab Pasudotox-Tdfk in Heavily Pretreated Patients with Relapsed/Refractory Hairy Cell Leukemia (HCL): Long-Term Follow-up from the Pivotal Phase 3 Trial

المؤلفون: Bjørn Tore Gjertsen, Philipp le Coutre, Wyndham H. Wilson, Ira Pastan, Tadeusz Robak, Claire Dearden, Priti Patel, Xavier Troussard, Douglas E. Gladstone, Lionel Karlin, Pier Luigi Zinzani, Julio Delgado, Robert J. Kreitman, Nataliya Kuptsova-Clarkson, Gail J. Roboz, Francis J. Giles, Shiyao Liu

المصدر: Blood. 134:2808-2808

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7d23b828ce57cb50cf580b059a1f6190Test
https://doi.org/10.1182/blood-2019-122307Test

78

Treatment-Free Remission (TFR) Following Frontline Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): 192-Weeks Data from the ENESTfreedom Study

المؤلفون: Tamás Masszi, Valentín García Gutiérrez, Bruno Martino, David M. Ross, Manu Sondhi, Andrzej Hellmann, Kaushal Mishra, Philipp le Coutre, María Teresa Gómez Casares, Jerald P. Radich, Eibhlin Conneally, Andreas Hochhaus, Paola Aimone, Jesper Stentoft, Susanne Saussele, Francis J. Giles, Norbert Gattermann, Giuseppe Saglio

المصدر: Clinical Lymphoma Myeloma and Leukemia. 19:S288

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Myeloid leukemia, Hematology, Nilotinib, Internal medicine, medicine, In patient, Chronic phase CML, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b8b162424d19ace9b39d6ea5faf4be75Test
https://doi.org/10.1016/j.clml.2019.07.232Test

79

Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial

المساهمون: Cortes, J, Kim, D, Pinilla-Ibarz, J, le Coutre, P, Paquette, R, Chuah, C, Nicolini, F, Apperley, J, Khoury, H, Talpaz, M, Deangelo, D, Abruzzese, E, Rea, D, Baccarani, M, Müller, M, Gambacorti-Passerini, C, Lustgarten, S, Rivera, V, Haluska, F, Guilhot, F, Deininger, M, Hochhaus, A, Hughes, T, Shah, N, Kantarjian, H

مصطلحات موضوعية: Male, Time Factors, Clinical Trials and Observations, NILOTINIB, Biochemistry, RECOMMENDATIONS, chemistry.chemical_compound, 0302 clinical medicine, MED/15 - MALATTIE DEL SANGUE, hemic and lymphatic diseases, 1114 Paediatrics And Reproductive Medicine, Cumulative incidence, Philadelphia Chromosome, IMATINIB-RESISTANT, BCR-ABL, Philadelphia chromosome positive, Aged, 80 and over, education.field_of_study, DASATINIB, Ponatinib, CHRONIC MYELOGENOUS LEUKEMIA, Imidazoles, Hematology, Middle Aged, Prognosis, Dasatinib, Pyridazines, Survival Rate, 030220 oncology & carcinogenesis, Female, Safety, TYROSINE KINASE INHIBITOR, Life Sciences & Biomedicine, medicine.drug, Adult, medicine.medical_specialty, Population, Immunology, Antineoplastic Agents, acute lymphoblastic leukemia, Philadelphia chromosome, 1102 Cardiovascular Medicine And Haematology, CML PATIENTS, 03 medical and health sciences, Young Adult, chronic myeloid leukemia, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, BCR-ABL INHIBITOR, medicine, Humans, Adverse effect, education, CHRONIC MYELOID-LEUKEMIA, Survival rate, Aged, Salvage Therapy, Science & Technology, business.industry, 1103 Clinical Sciences, Cell Biology, medicine.disease, chemistry, Nilotinib, Drug Resistance, Neoplasm, ADVERSE EVENTS, business, 030215 immunology, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ffe1d242e2941b0245f32c4df45b7e7Test
http://hdl.handle.net/10044/1/62990Test

80

Nilotinib

المؤلفون: Martin Gresse, Theo D. Kim, Philipp le Coutre

المصدر: Small Molecules in Hematology ISBN: 9783319914381

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::54a56881a2868643e83bcd548294306fTest
https://doi.org/10.1007/978-3-319-91439-8_3Test

تنقيح النتائج